CCND1 and prostate carcinoma: Furthermore, cancer stem cell radioresistance has been described in several cancer types including prostate cancer [49–50] and it will be of interest to test whether silencing cyclin D1 in PCa cells that express stem-like properties improves radiosensitivity.